{"nct_id":"NCT06695845","title":"A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-01-14","start_date_type":"ACTUAL","primary_completion_date":"2026-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JAZZ"]}